Daniel T. Verhamme;Keith Alan Charlton;Erik D'Hondt
发明人:
Keith Alan Charlton,Erik D'Hondt,Daniel T. Verhamme
申请号：
US16843118
公开号：
US20200297827A1
申请日:
2020.04.08
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present disclosure provides for a synthetic immunogenic protein for use as an immuno-modulatory agent to enhance mammalian immune reactions towards conjugated protein or peptide containing antigens that are otherwise poorly immunogenic, including but not limited to self-antigens. The chimeric immunogenic proteins of the present disclosure can be used in the treatment of many illnesses, including but not limited to cancers, infectious disease, autoimmune disease, allergies and any clinical indication involving or affected by the immune response of a mammalian host.
